Jannie Pedersen

Breadth of neutralization and synergy of clinically relevant human monoclonal antibodies against HCV genotypes 1a, 1b, 2a, 2b, 2c, and 3a

Thomas H. R. Carlsen, Jannie Pedersen, Jannick Prentoe et al. · Hepatology · 2014 · 82 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +15

Highly Efficient Infectious Cell Culture of Three Hepatitis C Virus Genotype 2B Strains and Sensitivity to Lead Protease, Nonstructural Protein 5A, and Polymerase Inhibitors

Santseharay Ramírez, Yi‐Ping Li, Sanne B. Jensen et al. · Hepatology · 2013 · 67 citations

Life Sciences, Infectious Diseases, Molecular Biology +15

HCV Genotype 6a Escape From and Resistance to Velpatasvir, Pibrentasvir, and Sofosbuvir in Robust Infectious Cell Culture Models

Long V. Pham, Santseharay Ramírez, Judith M. Gottwein et al. · Gastroenterology · 2018 · 47 citations

Life Sciences, Infectious Diseases, Microbiology +16

Neutralization resistance of hepatitis C virus can be overcome by recombinant human monoclonal antibodies

Jannie Pedersen, Thomas H. R. Carlsen, Jannick Prentoe et al. · Hepatology · 2013 · 38 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Cell Culture Studies of the Efficacy and Barrier to Resistance of Sofosbuvir-Velpatasvir and Glecaprevir-Pibrentasvir against Hepatitis C Virus Genotypes 2a, 2b, and 2c

Santseharay Ramírez, Carlota Fernandez-Antunez, Lotte S. Mikkelsen et al. · Antimicrobial Agents and Chemotherapy · 2019 · 21 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17